重大事件
即時報告
8-K
2026-06-08
CorMedix Inc. 提交8-K報告 披露選擇性資訊及新聞稿
AI 繁中摘要
CorMedix Inc.（CIK: 0001410098，紐交所上市代碼 CRMD）於 2026年6月8日 向 SEC 提交了一份 8-K 現行報告。📄 本次申報主要涉及兩項條款：Item 7.01（規例 FD 披露）及 Item 9.01（財務報表與附件）。公司同日發佈了一份新聞稿（附件 99.1），內容涵蓋 Regulation FD 項下的選擇性披露資訊。由於新聞稿全文未在摘要中展示，具體披露重點（如產品開發進展、監管更新或合作動態）需投資者查閱原始文件。🔍 8-K 屬即時性披露，通常預示對股價或業務有潛在影響的重大事件，建議投資者密切關注 CorMedix 官方渠道及後續文件，以評估其對公司短中期基本面的影響。💊🔬
展開英文正文
EDGAR Filing Documents for 0001213900-26-066061 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001213900-26-066061 Filing Date 2026-06-08 Accepted 2026-06-08 08:45:18 Documents 13 Period of Report 2026-06-08 Items Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 CURRENT REPORT ea0293895-8k_cormedix.htm iXBRL 8-K 40700 2 PRESS RELEASE DATED JUNE 8, 2026 ea029389501ex99-1.htm EX-99.1 11560 3 GRAPHIC ea029389501_ex99-1img1.jpg GRAPHIC 18616 Complete submission text file 0001213900-26-066061.txt 247460 Data Files Seq Description Document Type Size 4 XBRL SCHEMA FILE crmd-20260608.xsd EX-101.SCH 3014 5 XBRL LABEL FILE crmd-20260608_lab.xml EX-101.LAB 34239 6 XBRL PRESENTATION FILE crmd-20260608_pre.xml EX-101.PRE 22358 16 EXTRACTED XBRL INSTANCE DOCUMENT ea0293895-8k_cormedix_htm.xml XML 3196 Mailing Address 389 INTERPACE PKWY, SUITE 450 PARSIPPANY NJ 07054 Business Address 389 INTERPACE PKWY, SUITE 450 PARSIPPANY NJ 07054 908-517-9500 CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings) EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 261071141 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)